This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Smokeless Products' Strength to Drive Altria (MO) Q3 Earnings
by Zacks Equity Research
Altria's (MO) third-quarter 2017 results are likely to gain from revenue growth in the smokeless category. However, declining volumes have been limiting growth for smokeable products.
Philip Morris (PM) Q3 Earnings to Gain From iQOS Products
by Zacks Equity Research
Declining cigarette sales volumes expected to hurt Philip Morris' (PM) third-quarter results. However, the company expects significant growth in its heated tobacco products.
What Impact Will Self-Critical Ads Have on Tobacco Stocks?
by Zacks Equity Research
Increasing FDA regulation has dented tobacco companies' revenues significantly. The latest move to advertise against cigarettes is expected to raise concerns of accelerated sales declines for traditional cigarettes.
6 Reasons to Hold Philip Morris (PM) Despite Industry Woes
by Zacks Equity Research
Tobacco stocks are facing declining cigarette volumes amid increasing government restrictions and declining smoking rates. Nevertheless, Philip Morris can prove to be a boon for investors.
Here's Why You Should Hold on to Altria (MO) Stock Right Now
by Zacks Equity Research
Amid declining tobacco sales volumes and government restrictions, Altria (MO) has been benefiting from low-risk smokeless tobacco products.
4 High-Dividend Tobacco Picks to Add Value to Your Portfolio
by Zacks Equity Research
Tobacco stocks are facing declining cigarette volumes amid increasing government restrictions and declining smoking rates. Nevertheless, these stocks can prove to be a boon for investors.
Are Options Traders Betting on a Big Move in Altria Group (MO) Stock?
by Zacks Equity Research
Investors in Altria Group, Inc. (MO) need to pay close attention to the stock based on moves in the options market lately.
Tobacco Stocks Fall After FDA Targets Nicotine in Cigarette
by Zacks Equity Research
The news of cutting nicotine to non-addictive or minimally addictive levels have raised concerns of accelerated sales declines for traditional cigarettes, while demand for e-cigarettes is on the rise.
Tobacco Stocks Fall after FDA Announces New Nicotine Regulation Plan
by Megan Sanks
The U.S. Food and Drug Administration announced a plan on Friday to reduce tobacco-related disease and death by increasing regulations on tobacco and nicotine products.
Altria Group (MO) Lags Q2 Earnings; Revenue Beats Estimates
by Zacks Equity Research
Altria Group posts second quarter 2017 results,where earnings lagged the Zacks Consensus results, while revenues beat the same.
Tobacco Stocks Reporting Q2 Earnings on Jul 27: MO, VGR
by Zacks Equity Research
The tobacco stocks belong to the broader Consumer Staples sector and the second-quarter earnings' numbers for the sector looks decent.
Reynolds American's Acquisition by BAT Gets Shareholders' Nod
by Zacks Equity Research
Reynolds American (RAI) has finally got the shareholders' approval for its acquisition by BAT. Post-acquisition, the merged company will become the world's largest publicly traded tobacco entity.
Reynolds American (RAI) Stock Lacks Luster: What Lies Ahead?
by Zacks Equity Research
Reynolds American (RAI) is going through a tough time as evident from its dismal earnings and sales surprise history.
Why Is Altria (MO) Up 7.4% Since the Last Earnings Report?
by Zacks Equity Research
Altria (MO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Chevron, Altria, Kraft-Heinz and Time Warner
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chevron, Altria, Kraft-Heinz and Time Warner
Top Research Reports for Altria, Chevron, Kraft-Heinz & Time Warner
by Sheraz Mian
Today's Research Daily features new research reports on 17 major stocks, including Chevron (CVX), Altria (MO), Kraft Heinz (KHC) and Time Warner (TWX).
Altria Group (MO) Lags Q1 Earnings & Revenue Estimates
by Zacks Equity Research
Altria Group (MO) failed to meet earnings and revenues in the first quarter 2017.
Why Earnings Season Could Be Great for Altria (MO)
by Zacks Equity Research
Altria (MO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Top Research Reports for Today: BRK.B, ORCL, MRK
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Oracle (ORCL) and Merck (MRK).
Why Is Altria (MO) Up 6% Since the Last Earnings Report?
by Zacks Equity Research
Altria (MO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Philip Morris (PM) Stock Seems a Good Pick Right Now
by Zacks Equity Research
Despite the health related concerns associated with tobacco, one of the dominant players in this space, Philip Morris International Inc.'s (PM) has managed to entice investors on the back of strategic initiatives.
Philip Morris' IQOS Less Harmful as per Recent Research
by Zacks Equity Research
Philip Morris International Inc. (PM) has announced that its reduced-risk product ??? IQOS has been declared as safer than conventional cigarettes by a latest research conducted by Osaki Hospital Tokyo Heart Center.
Philip Morris (PM) Invests in Reduced Risk Tobacco Category
by Zacks Equity Research
In an attempt to combat declining volumes, Philip Morris International Inc. (PM) continues to boost presence in the unconventional tobacco category.
What's Behind the Rally in Tobacco Stocks?
by Zacks Equity Research
Despite the tobacco products carrying a stigma of health issues, the shares of tobacco titans portray a different picture with most reaching highs never seen before.
The Zacks Analyst Blog Highlights: Wells Fargo, Altria, Dow Chemical, Colgate and Papa John
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Wells Fargo, Altria, Dow Chemical, Colgate and Papa John